Press Resease

Brachytherapy Market by Technique (High Dose Rate and Low Dose Rate), by Application (Cervical Cancer, Prostate Cancer, Breast Cancer, Skin Cancer, and Others), and by End User (Hospitals and Oncology Treatment Centers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2025

Published Date: 06-Feb-2019 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3796 Status : Published

Global brachytherapy market expected to generate revenue of around USD 441 million by end of 2025, growing at a CAGR of around 4% between 2019 and 2025. Increasing awareness, technological advancement in the treatment of cancer, and extensive R&D will drive the brachytherapy market growth over the forecast period.

Description

The report covers forecast and analysis for the Brachytherapy Market on a global and regional level. The study provides historic data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the brachytherapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the brachytherapy market on a global level.

In order to give the users of this report a comprehensive view on the brachytherapy market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein technique, application, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Brachytherapy Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to the region.

The study provides a decisive view of the brachytherapy market by segmenting the market based on technique, application, end-user, and region. All the segments have been analyzed based on present and the future trends and the market is estimated from 2019 to 2025. Based on technique, the market is segmented into high dose rate and low dose rate. Key application segments covered under this study include cervical cancer, prostate cancer, breast cancer, skin cancer, and others. By end-user, the market is segmented into hospitals and oncology treatment centers.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for brachytherapy based on individual technique, technology, and end-user in all regions and countries.

The report also includes detailed profiles of market players such as Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Carl Zeiss Meditec AG, Argon Medical Devices Inc., Panacea Medical Technologies, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, and Varian Medical Systems, Inc., among others.

Global Brachytherapy Market: Technique Segment Analysis

  • High Dose Rate
  • Low Dose Rate 

Global Brachytherapy Market: Application Segment Analysis

  • Cervical Cancer
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer 
  • Others 

Global Brachytherapy Market: End-User Segment Analysis

  • Hospitals
  • Oncology Treatment Centers 

Global Brachytherapy Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Brachytherapy Market, 2017 - 2025(USD Million)
    • 2.2. Global Brachytherapy Market : Snapshot
  •  
  • Chapter 3. Brachytherapy Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Brachytherapy Market drivers: Impact analysis
      • 3.2.2. Growing prevalence of cancer globally
      • 3.2.3. Rising number of minimally invasive surgeries
      • 3.2.4. Short treatment time and improved efficiency
    • 3.3. Market restraints
      • 3.3.1. Global Brachytherapy Market restraints: Impact analysis
      • 3.3.2. Concerns regarding side effects based on the location of tumor
      • 3.3.3. Introduction of advanced radiotherapy
    • 3.4. Opportunities
      • 3.4.1. Increasing investments in the cancer treatment market
      • 3.4.2. Development of novel technologies
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by technique segment
      • 3.6.2. Market attractiveness analysis, by application segment
      • 3.6.3. Market attractiveness analysis, by end user segment
      • 3.6.4. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Brachytherapy Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Brachytherapy Market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development, and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Brachytherapy Market - Technique Segment Analysis
    • 5.1. Global Brachytherapy Market: Technique overview
      • 5.1.1. Global Brachytherapy Market revenue share, by techniques, 2017 and 2025
    • 5.2. High Dose Rate
      • 5.2.1. Global High Dose Rate Market, 2017 - 2025(USD Million)
    • 5.3. Low Dose Rate
      • 5.3.1. Global Low Dose Rate market , 2017 - 2025(USD Million)
  • Chapter 6. Global Brachytherapy Market - Application Segment Analysis
    • 6.1. Global Brachytherapy Market: Application overview
      • 6.1.1. Global Brachytherapy Market revenue share, by application, 2017- 2025
    • 6.2. Cervical Cancer
      • 6.2.1. Global Brachytherapy Market for Cervical Cancer, 2017 - 2025(USD Million)
    • 6.3. Prostate Cancer
      • 6.3.1. Global Brachytherapy Market for Prostate Cancer,2017 - 2025(USD Million)
    • 6.4. Breast Cancer
      • 6.4.1. Global Brachytherapy Market for Breast Cancer, 2017 - 2025(USD Million)
    • 6.5. Skin Cancer
      • 6.5.1. Global Brachytherapy Market for Skin Cancer, 2017 - 2025 (USD Million)
    • 6.6. Other Cancer
      • 6.6.1. Global Brachytherapy Market for Other Cancer, 2017 - 2025 (USD Million)
  •  
  • Chapter 7. Global Brachytherapy Market - End-user Segment Analysis
    • 7.1. Global Brachytherapy Market: End-user overview
      • 7.1.1. Global Brachytherapy Market revenue share, by end user , 2017and2025
    • 7.2. Hospitals
      • 7.2.1. Global Brachytherapy Market for Hospitals, 2017 - 2025(USD Million)
    • 7.3. Oncology Treatment Centers
      • 7.3.1. Global Brachytherapy Market for Oncology Treatment Centers, 2017 - 2025(USD Million)
  •  
  • Chapter 8. Global Brachytherapy Market - Regional Segment Analysis
    • 8.1. Global Brachytherapy Market: Regional overview
      • 8.1.1. Global Brachytherapy Market revenue share, by region, 2017 and 2025
    • 8.2. North America
      • 8.2.1. North America Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
      • 8.2.2. North America Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
      • 8.2.3. North America Brachytherapy Market revenue, by end user , 2017 - 2025(USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.2.4.2. U.S. Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.2.4.3. U.S. Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
      • 8.3.2. Europe Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
      • 8.3.3. Europe Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.3.4.2. Germany Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.3.4.3. Germany Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.3.5. France
        • 8.3.5.1. France Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.3.5.2. France Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.3.5.3. France Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.3.6. UK
        • 8.3.6.1. UK Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.3.6.2. UK Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.3.6.3. UK Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Brachytherapy Market revenue, by techniques, 2017 - 2025, (USD Million)
      • 8.4.2. Asia Pacific Brachytherapy Market revenue, by application, 2017 - 2025, (USD Million)
      • 8.4.3. Asia Pacific Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.4.4.2. China Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.4.4.3. China Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.4.5.2. Japan Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.4.5.3. Japan Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.4.6.2. India Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.4.6.3. India Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
      • 8.5.2. Latin America Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
      • 8.5.3. Latin America Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
        • 8.5.4.2. Brazil Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
        • 8.5.4.3. Brazil Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Brachytherapy Market revenue, by techniques, 2017 - 2025(USD Million)
      • 8.6.2. Middle East and Africa Brachytherapy Market revenue, by application, 2017 - 2025(USD Million)
      • 8.6.3. Middle East and Africa Brachytherapy Market revenue, by end user, 2017 - 2025(USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Eckert & Ziegler BEBIG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. IsoRay Medical, Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Carl Zeiss Meditec AG
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Argon Medical Devices Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Panacea Medical Technologies
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Elekta AB
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Boston Scientific Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. CR Bard Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. GE Healthcare
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Varian Medical Systems, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Methodology

Free Analysis

Brachytherapy places radioactive material on a permanent or temporary basis inside the body to damage cancer-causing cells and abolishes their capability to split and grow. Brachytherapy is a well-established type of internal radiation therapy in which the radioactive sources are used and placed right into the target area or around the tumor. As compared to therapy of external beam radiation, brachytherapy provides a high dose of radiation to precise positions in the body; the technique targets the tumor and reduces radiation to the nearby healthy tissue.

The increasing prevalence of various types of cancer incidences is majorly fueling the demand for the brachytherapy market. In 2016, around 1.6 million new cases of cancer were diagnosed in the U.S., according to the American Cancer Society (ACS). Moreover, increasing healthcare expenditure and rise in research funding for the treatment of cancer will significantly boost the brachytherapy market during the forecast period. Furthermore, high precision and accuracy of tumor-specific radiation dose delivery of high dose rate brachytherapy coupled with few side effects and speedy recovery will boost the brachytherapy market over the forecast period. However, the high costs of treatment are expected to hinder brachytherapy market growth.

Global Brachytherapy Market

Based on technique, the brachytherapy market has been segmented into high dose rate and low dose rate. By technique, the high dose rate segment is expected to register the highest growth rate over the forecast period. The high growth rate of this segment is attributed to the short period of the treatment and high accuracy. 

By application, the global brachytherapy market is segmented into cervical cancer, prostate cancer, breast cancer, skin cancer, and others. Breast cancer gained the highest market share in 2016 and is expected to show the highest CAGR over the forecast period. The prevalence of breast cancer across the globe is expected to drive the growth of the segment.

By end-user, the global brachytherapy market is segmented into hospitals and oncology treatment centers. Hospitals segment is estimated to dominate the global brachytherapy market over the forecast period. 

By region, the global brachytherapy market is segmented into five major regions North America, Asia Pacific, Europe, Middle East & Africa, and Latin America. North America is projected to remain the leading region over the forecast period. High prevalence of cancer and the adoption of advanced diagnostic techniques in the region is expected to enhance the growth of North America in global Brachytherapy market over the forecast period. Europe was the second largest market followed by the Asia Pacific. Asia Pacific market is estimated to grow at the highest growth rate during the forecast period, owing to the increasing disease burden of cancer along with the escalating population. Furthermore, rising cancer awareness and favorable government initiatives will accelerate market growth. Latin America and the Middle East & African markets are expected to experience moderate growth in the years to come.

Some of the key players in the global brachytherapy market include Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Carl Zeiss Meditec AG, Argon Medical Devices Inc., Panacea Medical Technologies, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, and Varian Medical Systems, Inc., among others. The rising demand for technically advanced products and aggregated competition among key players are expected to drive the growth of the brachytherapy market over the forecast period.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com